p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246
Clinical trial NCT03268382 · COMPLETED
Trial details
- NCT number
- NCT03268382
- Sponsor
- Aprea Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2019-07-10
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.